Great Idea Merck!

[Anonymous]

Here's an idea: Let's combine Januvia, a 4-year-old diabetes med, with Zocor, an ancient statin, and call it something new! As if Vytorin wasn't embarrassing enough. This company has become a complete joke.

Welcome to the New Merck.

 

[Anonymous]

Here's an idea: Let's combine Januvia, a 4-year-old diabetes med, with Zocor, an ancient statin, and call it something new! As if Vytorin wasn't embarrassing enough. This company has become a complete joke.

Welcome to the New Merck.

It's a VALUE ADDED product troll - go back to your space under the bridge at BMS.

 

[Anonymous]

Like Novartis didn't start it with combining amlodipine to lotensin and now we have the "Valturna/Tekturna" family...then Benicar does it, now Micardis doing the same thing...it took us a while.

 

[Anonymous]

Here's an idea: Let's combine Januvia, a 4-year-old diabetes med, with Zocor, an ancient statin, and call it something new! As if Vytorin wasn't embarrassing enough. This company has become a complete joke.

Welcome to the New Merck.

When all you have is a hammer ... . The real question is who the hell is paying a premium for this "value-adding" product and paying for how long?

 

[Anonymous]

I guess merck doesn't teach pharmacology anymore. they should really stop hiring reps at the mall. the combo products listed above are for the treatment of htn. here's how a doc views a combo. more drugs= more ae's. so now he can worry about the pancreas and the liver. of course he really should add metformin to the januvia. so why not a "tre-combo"? merck is just trying to re-capture the "old" glory of zocor. that ship has sailed.

 

[Anonymous]

Look, Merck can't even get a copycat version of Abbot's Niaspan approved. Ironically, Abbott has captured the first simvastatin version of that therapy as well. Merck is 100% me-too these days. And not very good at it - at that. Wait til they meet the real pros of me-too in India. Those that Merck cannot buy off will eat Merck's lunch.

 

[Anonymous]

I guess merck doesn't teach pharmacology anymore. they should really stop hiring reps at the mall. the combo products listed above are for the treatment of htn. here's how a doc views a combo. more drugs= more ae's. so now he can worry about the pancreas and the liver. of course he really should add metformin to the januvia. so why not a "tre-combo"? merck is just trying to re-capture the "old" glory of zocor. that ship has sailed.

Maybe if Merck showed some interest in healthcare & science it would change.

 

[Anonymous]

Maybe if Merck showed some interest in healthcare & science it would change.

Not when you have lawyers running the company which they have been doing for years but officially recently.

 

[Anonymous]

Not when you have lawyers running the company which they have been doing for years but officially recently.

Don't forget AZ's new approved drug VIMOVO or something like that combining naproxen with a PPI. Soon we'll be taking multi vitamin type combo pills on a qd po basis!!